CD30L (Protein|Antibody|cDNA Clone|ELISA Kit)

All CD30L reagents are produced in house and quality controlled, including 2 CD30L Antibody, 51 CD30L Gene, 6 CD30L Lysate, 6 CD30L Protein, 2 CD30L qPCR. All CD30L reagents are ready to use.

Recombinant CD30L proteins are expressed by HEK293 Cells with fusion tags as N-human IgG1-Fc, N-His, N-cleavage.

CD30L antibodies are validated with different applications, which are ELISA.

CD30L cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each CD30L of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.

CD30L Protein (6)

Species

CD30L Protein, Rat, Recombinant (Fc Tag)

80148-R01H

Expression host: HEK293 Cells

Rat CD153/CD30L/TNFSF8  Protein 12414

CD30L Protein, Human, Recombinant (Fc Tag)

10040-H01H

Expression host: HEK293 Cells

Human CD153/CD30L/TNFSF8  Protein 8323

CD30L Protein, Human, Recombinant

10040-HNCH

Expression host: HEK293 Cells

Human CD153/CD30L/TNFSF8  Protein 6234

CD30L Protein, Rat, Recombinant

80148-RNCH

Expression host: HEK293 Cells

Rat CD153/CD30L/TNFSF8  Protein 12415

CD30L Protein, Cynomolgus, Recombinant (His Tag)

90091-C07H

Expression host: HEK293 Cells

Cynomolgus CD153/CD30L/TNFSF8  Protein 12787

CD30L Protein, Cynomolgus, Recombinant (Fc Tag)

90091-C01H

Expression host: HEK293 Cells

Cynomolgus CD153/CD30L/TNFSF8  Protein 12786
Go

CD30L Antibody (2)

Application
Clonality
Host

Anti-CD30L Antibody

90091-RP01

Specificity: Cynomolgus

Application: ELISA

Clonality: PAb

Anti-CD30L Antibody

90091-T16

Specificity: Cynomolgus

Application: ELISA

Clonality: PAb

Go

CD30L cDNA Clone (51)

Rhesus
Rat
Human
Mouse

CD30L qPCR Primer (2)

CD30L Lysate (6)

CD3 ligand (CD3L), also known as CD153 and TNFSF8, is a membrane-associated glycoprotein belonging to the TNF superfamily and TNFR superfamily, and is a specific ligand for CD3/TNFRSF8 originally described as a cell surface antigen and a marker for Hodgkin lymphoma and related hematologic malignancies. CD3L is a type-II membrane glycoprotein expressed on activated T cells, stimulated monocyte-macrophages, granulocytes, eosinophils, and some Burkitt-like lymphoma cell lines. CD3L is capable of transducing signals through CD3 on different CD3+ lymphoma cell lines, and mediates pleiotropic biologic effects including cell proliferation, activation, differentiation, as well as cell death by apoptosis. CD3-CD3 ligand interaction has been suggested to have a pathophysiologic role in malignant lymphomas, particularly Hodgkin disease, large cell anaplastic lymphomas and Burkitt lymphomas, and is also involved in activation and functioning of the T cell-dependent immune response. Thus, CD153 and its receptor CD3 are regarded as therapeutic targets in hematologic malignancies, autoimmune and inflammatory diseases.
Protein
Antibody
Gene
qPCR
Lysate
Close